Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.

Abstract

Using preoperative PET/CT, we evaluated the prognostic value of preoperative [¹⁸F]FDG uptake ratio between various metastatic lesions and primary tumour in patients with advanced serous epithelial ovarian cancer (EOC). We retrospectively reviewed patients with International Federation of Gynecology and Obstetrics (FIGO) stage III, IV serous EOC who underwent preoperative [¹⁸F]FDG PET/CT scans. Clinico-pathological variables and PET/CT parameters such as maximum standardized uptake value of the ovarian cancer (SUV_ovary), pelvic or para-aortic LN (SUV_LN), peritoneal (SUV_perit) and distant extra-peritoneal (SUV_dist) metastatic lesions, and the metastatic lesion-to-ovarian cancer standardized uptake value ratio were assessed. Clinico-pathological data were retrospectively reviewed for 97 eligible patients. The median progression-free survival (PFS) was 18 months (range, 6-90 months) and 59 (60.8 %) patients experienced recurrence. In multivariate regression analysis, older age (p = 0.035, hazard ratio (HR) 1.032, 95 % CI 1.002-1.062), and high SUV_perit/SUV_ovary (p = 0.046, HR 1.755, 95 % CI 1.011-3.047) were independent risk factors of recurrence. Patient group categorized by SUV_perit/SUV_ovary showed significant difference in PFS (Log-Rank test, p = 0.001). In patients with advanced serous EOC, preoperative SUV_perit/SUV_ovary measured by [¹⁸F]FDG PET/CT provides significant incremental performance for prediction of recurrence. • PET/CT data from advanced serous epithelial ovarian cancer patients were analysed. • Prognostic value of SUV ratio between metastatic and primary tumour was investigated. • SUV _perit /SUV _ovary provides incremental performance for prediction of recurrence.